| |
| |
|
| Insider
Information: |
Wilson Mark Andrew |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
236,674 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$345,544 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
236,674 |
|
|
| Total
Value |
$345,544 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
|
2024-02-20 |
236,674 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2024-02-20 |
4 |
S |
$0.68 |
$5,172 |
D/D |
(7,606) |
236,674 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2023-11-17 |
4 |
S |
$0.49 |
$3,518 |
D/D |
(7,179) |
243,780 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2023-08-16 |
4 |
S |
$0.78 |
$5,632 |
D/D |
(7,221) |
250,959 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2023-05-16 |
4 |
S |
$0.72 |
$5,431 |
D/D |
(7,543) |
257,680 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2023-02-16 |
4 |
S |
$3.00 |
$24,825 |
D/D |
(8,275) |
265,223 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief Legal Officer |
• – – |
2022-11-16 |
4 |
S |
$3.57 |
$31,023 |
D/D |
(8,690) |
272,498 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2022-08-16 |
4 |
S |
$4.76 |
$15,180 |
D/D |
(3,189) |
281,188 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
165,938 |
284,377 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2022-05-16 |
4 |
S |
$3.95 |
$12,387 |
D/D |
(3,136) |
117,939 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2022-02-16 |
4 |
S |
$10.95 |
$40,088 |
D/D |
(3,661) |
121,075 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,800 |
124,736 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-11-16 |
4 |
S |
$13.16 |
$86,382 |
D/D |
(6,564) |
86,436 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,100 |
93,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-08-16 |
4 |
S |
$13.83 |
$26,415 |
D/D |
(1,910) |
72,900 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-05-17 |
4 |
S |
$18.30 |
$35,081 |
D/D |
(1,917) |
74,810 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-02-16 |
4 |
S |
$22.37 |
$48,610 |
D/D |
(2,173) |
76,727 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-02-03 |
4 |
OE |
$8.80 |
$47,027 |
D/D |
5,344 |
84,244 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2021-02-03 |
4 |
AS |
$19.45 |
$103,941 |
D/D |
(5,344) |
78,900 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,550 |
78,900 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2020-11-16 |
4 |
S |
$16.93 |
$26,055 |
D/D |
(1,539) |
49,850 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2020-08-17 |
4 |
S |
$19.67 |
$30,075 |
D/D |
(1,529) |
51,389 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General Counsel |
• – – |
2020-05-18 |
4 |
S |
$22.51 |
$34,418 |
D/D |
(1,529) |
52,418 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & General CounselOfficer |
• – – |
2020-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,947 |
|
% |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
